DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors
Abstract
IL-6 is a multifunctional cytokine that is important for immune responses, cell survival, apoptosis, and proliferation. However, little is known about the correlation between the IL-6 signaling pathway and DNA damage in human tumors. The present study demonstrates the role of the IL-6/STAT3 signaling pathway in human tumor cells exposed to DNA damage. Tumor cells exposed to DNA damage increase the expression and secretion of IL-6 and the phosphorylation of JAK1 and STAT3. The activation of the JAK1-STAT3 signaling pathway is inhibited by knockdown of gp130 or neutralization of soluble IL-6, implying that DNA damage induces the phosphorylation of JAK1 and STAT3 by autocrine IL-6. Interestingly, inhibition of the IL-6/STAT3 signaling pathway impairs the growth of tumor cells exposed to DNA damage and results in the induction of senescence. Therefore, the present study suggests that IL-6 inhibits senescence but promotes the survival and proliferation of tumor cells exposed to DNA damage through the activation of the JAK1-STAT3 signaling pathway.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Antibody against IL-6, gp130 siRNA, or dominant-negative STAT3 enhance chemo-induced death in lymphoma and colon cancer.
“Antibody against IL-6, gp130 siRNA, or dominant-negative STAT3 enhanced chemo-induced death in lymphoma (Gilbert and Hemann, 2010), as well as colon cancer (Yun et al., 2012)”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Yun et al., 2012
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · see citing works
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · see citing works
Requirement for p53 and p21 to Sustain G <sub>2</sub> Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · see citing works
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790 · see citing works
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232 · see citing works
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · see citing works
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · see citing works
Gp130 and the interleukin-6 family of cytokines.
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,603 · see citing works
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170 · see citing works
The role of IL-6 and STAT3 in inflammation and cancer.
Hodge, D., Hurt, E. M., & Farrar, W. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 991 · see citing works
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946 · see citing works
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779 · see citing works
The Stat family in cytokine signaling
Ihle, J. N. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00199-x · Cited by 713 · see citing works
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666 · see citing works
Initiating Cellular Stress Responses
Bakkenist, C. J., & Kastan, M. B. (2004) · Cell · doi:10.1016/j.cell.2004.06.023 · Cited by 544 · see citing works
Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli
Wu, Z., Shi, Y., Tibbetts, R. S., & Miyamoto, S. (2006) · Science · doi:10.1126/science.1121513 · Cited by 515 · see citing works
DNA Damage-Mediated Induction of a Chemoresistant Niche
Gilbert, L. A., & Hemann, M. T. (2010) · Cell · doi:10.1016/j.cell.2010.09.043 · Cited by 428 · see citing works
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422 · see citing works
Interleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics
Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370 · see citing works
Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
Sugrue, M. M., Shin, D. Y., Lee, S. W., & Aaronson, S. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9648 · Cited by 290 · see citing works
Self-citationDominant Negative Stat3 Mutant Inhibits Interleukin-6-induced Jak-STAT Signal Transduction (*)
Kaptein, A., Paillard, V., & Saunders, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.5961 · Cited by 264 · see citing works
PIASy mediates NEMO sumoylation and NF-κB activation in response to genotoxic stress
Mabb, A. M., Wuerzberger‐Davis, S. M., & Miyamoto, S. (2006) · Nature Cell Biology · doi:10.1038/ncb1458 · Cited by 226 · see citing works
Activation of Transcription Factor NF-κB Requires ELKS, an IκB Kinase Regulatory Subunit
Sigala, J. L. D., Bottero, V., Young, D. B., Shevchenko, A., Mercurio, F., & Verma, I. M. (2004) · Science · doi:10.1126/science.1098387 · Cited by 220 · see citing works
Cytokine-Dependent Imatinib Resistance in Mouse Bcr-Abl(+), Arf-Null Lymphoblastic Leukemia.Preprint
Williams, R. T., den Besten, W., Boulos, N., & Sherr, C. J. (2007) · Genes & Development · doi:10.1101/gad.1588607 · Cited by 178 · see citing works
Mabb, A. M., & Miyamoto, S. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7005-2 · Cited by 100 · see citing works
IL-6: From Laboratory to Bedside
Kishimoto, T. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:3:177 · Cited by 71 · see citing works
Goldstein, S., Moerman, E. J., Fujii, S., & Sobel, B. E. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610321 · Cited by 59 · see citing works
DUMONT, P., BALBEUR, L., Remacle, J., & Toussaint, O. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19740529.x · Cited by 54 · see citing works
Deregulation of Cdk2 causes Bim-mediated apoptosis in p53-deficient tumors following actin damage
Chae, H., Kim, B. M., Yun, U.-J., & Shin, D. Y. (2008) · Oncogene · doi:10.1038/onc.2008.46 · Cited by 22 · see citing works
Self-citationJung, M., Jin, D., Chae, H., Kang, S., Kim, S., Bang, Y., Choi, T., Choi, K., & Shin, D. (2004) · AJOU Open Repository (Ajou University) · doi:10.1074/jbc.m305015200
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S. R., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,096 · see citing works
Secretion of immunoregulatory cytokines by mesenchymal stem cells
Kyurkchiev, D. S. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.552 · Cited by 619 · see citing works
Physiological and molecular determinants of embryo implantation
Zhang, S., Lin, H., Kong, S., Wang, S., Wang, H., Wang, H., & Armant, D. R. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.011 · Cited by 592 · see citing works
Ferguson, L. R., Chen, H., Collins, A. R., Connell, M., Damia, G. L. M., Dasgupta, S., Malhotra, M., Meeker, A. K., Amedei, A., Amin, A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.005 · Cited by 340 · see citing works
Bharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314 · see citing works
“Antibody against IL-6, gp130 siRNA, or dominant-negative STAT3 enhanced chemo-induced death in lymphoma (Gilbert and Hemann, 2010), as well as colon cancer (Yun et al., 2012), indicating that targeting IL-6/STAT3 signaling may be a viable strategy for bypassing senescence-induced chemoresistance.”
BackgroundCharacterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation
Li, W., Hu, X., Wang, S., Jiao, Z., Sun, T., Liu, T., & Song, K. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.189 · Cited by 279 · see citing works
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
Zhang, J., Dang, F., Ren, J., & Wei, W. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.09.004 · Cited by 229 · see citing works
Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Hooijer, G. K. J., Meijer, S. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820459116 · Cited by 183 · see citing works
IL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170 · see citing works
Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Burgess, J. K., Mutsaers, S. E., Prêle, C. M., Schuliga, M. J., Grainge, C., & Knight, D. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2018 · Cited by 167 · see citing works
Han, D., Gong, H., Wei, Y., Xu, Y., Zhou, X., Wang, Z., & Feng, F. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154680 · Cited by 118 · see citing works
Datta, R., Bansal, T., Rana, S., Datta, K., Chaudhuri, R. D., Chawla‐Sarkar, M., & Sarkar, S. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00611-16 · Cited by 114 · see citing works
Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets
Luan, Y., Zhu, X., Jiao, Y., Liu, H., Huang, Z., Pei, J., Xu, Y., Yang, Y., & Ren, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01792-5 · Cited by 106 · see citing works
DNA Damage and Pulmonary Hypertension
Ranchoux, B., Meloche, J., Paulin, R., Boucherat, O., Provencher, S., & Bonnet, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060990 · Cited by 105 · see citing works
Herbstein, F., Sapochnik, M., Attorresi, A. I., Pollak, C., Senin, S. A., Gonilski‐Pacin, D., del Giudice, N. C., Fiz, M., Elguero, B., Fuertes, M., et al. (2024) · Aging Cell · doi:10.1111/acel.14258 · Cited by 101 · see citing works
Antitumor and immunomodulatory effects of a water-soluble polysaccharide from Lilii Bulbus in mice
Sun, X., Gao, R., Yao-kang, X., Huang, Q.-C., & Xu, M. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.12.002 · Cited by 92 · see citing works
Immune-enhancing effects of polysaccharides extracted from Lilium lancifolium Thunb
Pan, G., Xie, Z., Huang, S., Tai, Y., Cai, Q., Jiang, W., Sun, J., & Yuan, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.030 · Cited by 88 · see citing works
Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
Yu, M., Bin, L., Liu, Y., Me, Y., Wang, L., & Zhang, P. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6065 · Cited by 69 · see citing works
Prognostic implication of TIM-3 in clear cell renal cell carcinoma
Yuan, J., Jiang, B., Zhao, H., & Huang, Q. B. (2013) · Neoplasma · doi:10.4149/neo_2014_006 · Cited by 68 · see citing works
Garbers, C., Kuck, F., Aparicio-Siegmund, S., Konzak, K., Kessenbrock, M., Sommerfeld, A., Häussinger, D., Lang, P. A., Brenner, D., Mak, T. W., et al. (2013) · Cell Cycle · doi:10.4161/cc.26431 · Cited by 64 · see citing works
Wang, Z., Yan, J., Lin, H., Hua, F., Wang, X., Liu, H., Lv, X., Yu, J., Mi, S., Wang, J., et al. (2013) · Hepatology · doi:10.1002/hep.26234 · Cited by 63 · see citing works
Meng, F., Ning, Y.-L., Jia, Q., He, Z., Jie, J., Lin, J., Huang, Y.-J., Li, F.-S., & Li, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15035140 · Cited by 61 · see citing works
Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer
Piao, Y.-R., Piao, L., Zhu, L., Jin, Z., & Dong, X.-Z. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.6.3897 · Cited by 60 · see citing works
Ge, Z., Feng, Y., Ge, L., Parry, N. M., Muthupalani, S., & Fox, J. G. (2017) · Cellular Microbiology · doi:10.1111/cmi.12728 · Cited by 57 · see citing works
Zhong, W., Zhu, Z., Xu, X., Zhang, H., Xiong, H., Li, Q., & Wei, Y. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1081-7 · Cited by 55 · see citing works
Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis
Igietseme, J. U., Omosun, Y., Stuchlik, O., Reed, M. S., Partin, J. V., He, Q., Joseph, K., Ellerson, D., Bollweg, B. C., George, Z., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145198 · Cited by 52 · see citing works
Js, L., Lee, J.-S., Cui, M. N., Yun, H. H., Kim, H. Y., Lee, S. H., & Lee, J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.501 · Cited by 51 · see citing works
Chen, L., Liu, P., Chen, Y., Tseng, H., Shen, P.-C., Hwang, P., & Hsu, H.-L. (2017) · Scientific Reports · doi:10.1038/s41598-017-12111-1 · Cited by 49 · see citing works
Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression
Chen, L., Tseng, H., Chen, Y., Haq, A. T. A., Hwang, P., & Hsu, H.-L. (2020) · Cancers · doi:10.3390/cancers12020421 · Cited by 42 · see citing works
Mao, G., Zhang, Z.-H., Fei, F., Ding, Y., Zhang, W., Chen, H., Ali, S. S., Zhao, T., Feng, W., Wu, X., et al. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.073 · Cited by 40 · see citing works
Programmed cell senescence: role of IL-6 in the pituitary
Sapochnik, M., Fuertes, M., & ARZT, E. S. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0026 · Cited by 37 · see citing works
Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment
Nehme, R., Hallal, R., Dor, M. E., Kobeissy, F. H., Gouilleux, F., Mazurier, F., & Zibara, K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908114411 · Cited by 34 · see citing works
On the significance of Tim-3 expression in pancreatic cancer
Peng, P., Li, Y., & Sun, S. (2017) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2017.11.006 · Cited by 29 · see citing works
Pharmacological Targeting of STING-Dependent IL-6 Production in Cancer Cells
Al-Asmari, S. S., Rajapakse, A., Ullah, T. R., Pépin, G., Croft, L. V., & Gantier, M. P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.709618 · Cited by 28 · see citing works
C-reactive protein (CRP) promotes malignant properties in pancreatic neuroendocrine neoplasms
Schimmack, S., Yang, Y.-C., Felix, K., Herbst, M., Li, Y., Schenk, M., Bergmann, F., Hackert, T., & Strobel, O. (2019) · Endocrine Connections · doi:10.1530/ec-19-0132 · Cited by 21 · see citing works
DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS–STING signalling
Wheeler, O. P. G., & Unterholzner, L. (2023) · Essays in Biochemistry · doi:10.1042/ebc20220241 · Cited by 26 · see citing works
ATM and p53 in aging and cancer: a double-edged sword in genomic integrity
Pandey, S. N., Afzal, M., Uikey, J., Ganesan, S., Mishra, S., Bansal, P., Kazmi, I. A., Alzarea, S. I., Almalk, W. H., Goyal, K., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10249-4 · Cited by 21 · see citing works
Liu, J., Zheng, R., Zhang, Y., Jia, S., He, Y., & Liu, J. (2023) · Cancers · doi:10.3390/cancers15092640 · Cited by 19 · see citing works
Khanna, A., Thoms, J. A. I., Stringer, B. W., Chung, S. A., Ensbey, K. S., Jue, T. R., Jahan, Z., Subramanian, S., Anande, G., Shen, H. M., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0934 · Cited by 19 · see citing works
A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma.
Li, Z., Zhu, T., Xu, Y., Wu, C., Chen, J., Ren, Y., Kong, L., Sun, S., Guo, W., Wang, Y., et al. (2019) · PubMed Central · Cited by 18 · see citing works
Ngo, A. T., Hang, L. M., Nhung, T. T. H., Jun, A. P. G., Bach, T. Q., Bui, H. T. H., Hoang, V. T., Bui, A. V., Liêm, N. T., & Hoang, D. M. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17016 · Cited by 16 · see citing works
Tsai, M., Hsu, Y., Wu, K., Yang, R., Chen, Y., Yu, H., & Kuo, P. (2013) · Current Eye Research · doi:10.3109/02713683.2012.763103 · Cited by 17 · see citing works
Yang, Y., Yang, L., & Li, Y. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.06.030 · Cited by 16 · see citing works
Houssein, M., Saab, W. F. A., Khalil, M. I. M., Khalife, H. K., & Fatfat, M. (2020) · Current Therapeutic Research · doi:10.1016/j.curtheres.2020.100589 · Cited by 15 · see citing works
Prabaharan, C. B., Yang, A. B., Chidambaram, D., Rajamanickam, K., Napper, S., & Sakharkar, M. K. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00837-w · Cited by 15 · see citing works
Suzuki, K., Chosa, N., Sawada, S., Takizawa, N., Yaegashi, T., & Ishisaki, A. (2017) · Stem Cells International · doi:10.1155/2017/3296498 · Cited by 14 · see citing works
Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells
Hallal, R., Nehme, R., Brachet‐Botineau, M., Nehme, A., Dakik, H., Deynoux, M., Sbarba, P. D., Vern, Y. L., Zibara, K., Gouilleux, F., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15612 · Cited by 13 · see citing works
Zhang, S., Zhang, H., Jin, Z., Wang, S., Wang, Y., Zhu, L., Sun, W. S., & Yan, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29519 · Cited by 13 · see citing works
Yang, L., Yu, X., & Yang, Y. (2018) · Endocrine Connections · doi:10.1530/ec-18-0356 · Cited by 12 · see citing works
Hsu, H.-W., de Necochea-Campion, R., Williams, V. M., Duerksen-Hughes, P. J., Simental, A., Ferris, R. L., Chen, C.-S., & Mirshahidi, S. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.03.006 · Cited by 12 · see citing works
Li, L., Hu, X., Nkwocha, J., Sharma, K., Kmieciak, M., Mann, H., Zhou, L., & Grant, S. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00817-6 · Cited by 10 · see citing works
Quantification of Cytokines in Lip Tissue from Infants Affected by Congenital Cleft Lip and Palate
Pilmane, M., Jain, N., Jain, S., Akota, I., & Kroiča, J. (2021) · Children · doi:10.3390/children8020140 · Cited by 10 · see citing works
Olekšák, P., Rysanek, D., Vančurová, M., Vašicová, P., Urbancokova, A., Novak, J. F., Maurencova, D., Kashmel, P., Houserova, J., Mikyšková, R., et al. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00190 · Cited by 6 · see citing works
Novel radiation and targeted therapy combinations for improving rectal cancer outcomes
Pennel, K. A. F., Dutton, L. R., Melissourgou-Syka, L., Roxburgh, C. S. D., Birch, J. L., & Edwards, J. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.15 · Cited by 6 · see citing works
Guo, X., Hao, H., Meng, A., Xu, C. J., Ma, Y., Sun, F., & Chen, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/3387396 · Cited by 6 · see citing works
Wang, C., Huang, C., Chen, L.-J., Chen, G., & Hong, S. (2025) · Cancers · doi:10.3390/cancers17182950 · Cited by 5 · see citing works
Li, S., Xie, M., Du, Y., & Tan, Z. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02235-7 · Cited by 5 · see citing works
New insights into the role of cellular senescence and rheumatic diseases
Wen, J., Li, J., Wan, L., & Wang, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1557402 · Cited by 4 · see citing works
Demethylation of SOCS1 mediates its abnormally high expression in ovarian cancer
Li, X., Kong, C., Fan, Y.-C., Liu, J., Lu, W., Meng, C., Li, A., Zhai, A., Yan, B., Song, W., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10451 · Cited by 4 · see citing works
Becerril, J. L. M., Benítez, J. G. S., Torres-Juárez, J. J., Bañales, J. M., Zerón, H. M., & Navarro, M. D. H. (2015) · Biochemical Genetics · doi:10.1007/s10528-015-9691-z · Cited by 3 · see citing works
Ge, J., Zhang, X., Wang, F., Wang, Y., Li, Q., Wei, T., & Ren, G. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2015.09.008 · Cited by 3 · see citing works
Huang, T., Yang, M., Grant, C., Kelly, K., O’Connor, A. J., Kalionis, B., & Heath, D. E. (2025) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbma.70010 · Cited by 2 · see citing works
Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment
Nehme, R. (2021) · Current Medicinal Chemistry · doi:10.2174/1875533xmta5enzg5y · Cited by 2 · see citing works
Estêvão, D., da Cruz-Ribeiro, M., Canha‐Borges, A., Macedo‐Silva, C., Castro, F., Lencart, J., Boterberg, T., Sousa, O., Jerónimo, C., Duarte, I. F., et al. (2025) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2025.111288 · Cited by 1 · see citing works
Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment
Polderdijk, M. C. E., Heron, M., Kuipers, S., & Rijkers, G. T. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1641405 · Cited by 1 · see citing works
Potential Mechanisms Linking Oxidized LDL to Susceptibility to Cancer
Khaidakov, M., & Mehta, J. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5857-9_19
Investigating the interactions between nonoparticles and UV-irradiated HaCaT keratinocytes
Patsikatheodorou, N. (2014) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27333276
Az interleukin-6-expresszió vizsgálata colorectalis adenocarcinomában szenvedő betegeken
Jósa, V., Féderer, K., Zrubka, Z., Reiniger, L., & Baranyai, Z. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32206
- Authors
- Yun, U. J., Park, S. E., Jo, Y. S., Kim, J., & Shin, D. Y.
- Affiliations
- Seoul National University (KR)
- Dankook University (KR)
- Corresponding author
- Shin, Deug Y.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 323
- Issue
- 2
- Pages
- 155-160
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W1989338259
- Cited by
- 69
- References
- 30
- Citations by year
- 2025: 6 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 5 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 9
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Science and Technology
- Ministry of Health and Welfare
- National Research Foundation of Korea
- Topics
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Keywords
- interleukin-6, STAT3, JAK1, DNA damage, tumor cell senescence, gp130, tumor cell proliferation, tumor cell survival
- MeSH terms
- Base Sequence, Cell Division, DNA Damage, Humans, Neoplasms, Interleukin-6, Cellular Senescence, DNA Primers, Gene Silencing, Cell Line, Tumor, STAT3 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review